Author

F. Özkalemkaş

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Immunoglobulin A Subtype and Survival After Upfront Autologous Stem Cell Transplantation in Multiple Myeloma: A Real-World Cohort from the Bortezomib Era

Simple Summary Multiple myeloma is a cancer of plasma cells, which secrete an abnormal antibody. The class of that antibody is identified in every patient during routine diagnostic work-up at no additional cost, but it plays no part in the scores used to assess disease aggressiveness. We reviewed 196 patients who recei...

Tuba Güllü Koca, Nizameddin Koca, F. Hunutlu et al. · Cancers · 0 citations

Open access Sep 2026

Exploratory Analysis of the C-Reactive Protein–Albumin–Lymphocyte Index and Progression-Free Survival in Early-Stage Classical Hodgkin Lymphoma

A low pre-treatment CALLY index was associated with shorter progression-free survival in early-stage cHL; this hypothesis-generating finding requires external and positron-emission-tomography-adapted validation.

Tuba Güllü Koca, Nizameddin Koca, F. Hunutlu et al. · Uludağ Üniversitesi Tıp Fakü... · 0 citations

Open access Apr 2026

RNA sequencing detects more challenging cases of somatic hypermutation in the IgHV gene in patients with chronic lymphocytic leukemia

Background/aim Chronic lymphocytic leukemia (CLL) exhibits marked biological heterogeneity, and immunoglobulin heavy chain variable (IgHV) mutation status remains a key prognostic biomarker. We evaluated patient IgHV status via RNA sequencing (RNA-seq) and examined real-life clinical outcomes in a retrospective CLL coh...

F. Arıkan, P. Ata, Şenol Demir et al. · Turkish Journal of Medical S... · 0 citations